Experimental HIV vaccine generates broadly neutralising antibodies in primates
Researchers have developed an experimental HIV vaccine that successfully generated broadly neutralizing antibodies in non-human primates. By using a germline-targeting approach to guide B-cell development, the team aims to overcome the virus's ability to mutate and evade the immune system.
Why it matters
This represents a significant scientific breakthrough in the long-standing effort to create a vaccine that can effectively prevent HIV infection.
Experimental HIV vaccine generates broadly neutralising antibodies in primates
Scientific reporting on medical research; objective and factual.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in